Bladder augmentation is an essential adjunct in the treatment of neurogenic bladder dysfunction in children; however, it carries with it many risks, of which both patients and their physicians must be ...

Graphical comparison of bladder augmentation surgery using either ileum (top) or a cell-seeded, biodegradable scaffold (bottom). MSCs and HSPCs represent different types of stem cells found in the ...

Use of bowel segments for bladder augmentation has recognized long-term complications—perforation, stone formation, electrolyte disturbances and cancer—attributed to the presence of secretory mucosa ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant. The surgery was successfully completed at Ronald Reagan UCLA Medical Center on May 4, ...

Doctors consider surgery for interstitial cystitis (IC) as a last resort when other treatments, such as diet changes, medications, bladder instillations, and physical therapy, have failed to bring ...

Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...